Key result
Hypercholesterolemia is not associated with differences in baroreflex sensitivity in patients with sleep-disordered breathing.
Why the study?
Clinical data linking sleep-disordered breathing with dyslipidemia and the proposed linking role of autonomic dysfunction are limited.
Is sleep-disordered breathing associated with dyslipidemia and autonomic dysfunction in healthy habitual snorers?
Cross-Sectional (n=110)
No
Is sleep-disordered breathing associated with dyslipidemia and autonomic dysfunction in healthy habitual snorers?
Absolute Event Rate: 7.3% vs 8.2%
p-value: p=0.463
In healthy habitual snorers, sleep-disordered breathing severity (minimal nocturnal oxygen saturation) is associated with higher triglyceride levels, but this does not appear to be mediated by autonomic dysfunction as measured by baroreflex sensitivity.
No difference in baroreflex sensitivity by hypercholesterolemia status; leaves open non-autonomic pathways linking nocturnal desaturation to triglycerides.
Objectives. Although multiple mechanisms, including autonomic dysfunction, seem to link sleep-disordered breathing (SDB) with dyslipidemia in animal studies, the data in clinical studies are limited. The aim of this study was to explore the association of lipoprotein levels with SDB measures in healthy habitual snorers. We supposed that autonomic dysfunction is the linking mechanism. Methods. We enrolled 110 previously healthy subjects with complaints of habitual snoring. To assess SDB, polysomnography was performed. Blood samples for the analysis of total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein cholesterol (LDL), and triglycerides (TG) were obtained in a fasting condition after the polysomnography. Baroreflex sensitivity (BRS) was used to assess the autonomic dysfunction. Results. In stepwise multiple linear regression analysis, minimal nocturnal blood oxygen saturation (beta=–0.240, p=0.020) and neck circumference (beta=0.224, p=0.03) were the only significant contributors in model predicting TG. SDB measures were not identified as significant contributors in models predicting TC, LDL, and HDL. We failed to find any significant difference in BRS in SDB subjects when compared according to the presence or absence of hypercholesterolemia/ hypertriglyceridemia. In SDB subjects, the area under the curve in a receiver operating curve to predict hypercholesterolemia and hypertriglyceridemia by BRS was 0.468 (95% CI: 0.328–0.608) and 0.425 (95% CI: 0.304–0.546), respectively. Conclusions. Our results suggest that minimal nocturnal blood oxygen saturation is significant contributor in model predicting TG. No significant decrease in BRS was found in SDB subjects with hypercholesterolemia and hypertriglyceridemia. In SDB subjects, the role of autonomic dys-function in the development of dyslipidemia remains controversial.
No takes yet. Share an insight, caveat, or question.
Šiarnik et al. (2021) conducted a cross-sectional in Sleep-disordered breathing (n=110). Sleep-disordered breathing with hypercholesterolemia vs. Sleep-disordered breathing without hypercholesterolemia was evaluated on Baroreflex sensitivity (BRS) (p=0.463). In subjects with sleep-disordered breathing, baroreflex sensitivity did not significantly differ between those with and without hypercholesterolemia (median 7.3 vs. 8.2 ms/mmHg, p=0.463).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: